A synbiotic formula (SIM01) developed by Hong Kong firm GenieBiome in collaboration with the Chinese University of Hong Kong has been shown to alleviate multiple symptoms of post-acute COVID-19 syndrome (PACS), while also benefiting children after their...
Researchers are open to the possibilities of supplement use to modify the gut microbiome as an aid to recovery from post-acute COVID-19 syndrome or ‘Long COVID.’